Ticker
ARVNCompany Name
ARVINAS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 9.9M | $ 609.3M | $ 619.2M |
3/31/2025 | $ 10.5M | $ 660.1M | $ 670.6M |
12/31/2024 | $ 9.7M | $ 561.7M | $ 571.4M |
9/30/2024 | $ 1.5M | $ 586M | $ 587.5M |
6/30/2024 | $ 2.1M | $ 600.2M | $ 602.3M |
3/31/2024 | $ 2.6M | $ 609.7M | $ 612.3M |
12/31/2023 | $ 3.2M | $ 660M | $ 663.2M |
9/30/2023 | $ 4M | $ 457.2M | $ 461.2M |
6/30/2023 | $ 4.5M | $ 463.6M | $ 468.1M |
3/31/2023 | $ 5M | $ 511M | $ 516M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for ARVINAS INC is calculated as follows: Debt [ $ 4.29M ] + Equity [ $ 205.12M ]
(=) Inv. Capital [ $ 209.41M ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.11B |
average | $ 760.31M |
median | $ 303.21M |
std | $ 1B |